In Vitro Fertilization (IVF)

Treatment with In Vitro Fertilization (IVF) involves several steps 1) the development of follicles (pockets of fluid that contain the eggs) in the woman’s ovaries- referred to as “ovarian stimulation” 2) the removal of eggs (oocytes) from her ovaries- referred to as “egg or oocyte retrieval” 3) The patient’s partner, if applicable, will typically be required to collect a semen sample on the day of oocyte retrieval. Exceptions to this include those patients using donor sperm, those utilizing a previously frozen semen sample or those having surgical retrieval of tissue or sperm extraction. 4) the fertilization of the eggs in the laboratory- referred to as “fertilization of oocytes” 5) transfer of embryos (fertilized eggs) into the (a) woman’s uterus- referred to as “embryo transfer. Patients are not guaranteed success at any or all of these steps. If adequate results are not achieved at any step, the cycle may be cancelled at the discretion of an RMIA physician.

Preimplantation Genetic Screening (PGS) or Preimplantation Genetic Diagnosis (PGD) is a process of screening early embryos during the in vitro process. The oocytes are retrieved, fertilized using ICSI, and after three days of growth, biopsied to obtain genetic material needed to screen the embryos. After this biopsy occurs, the embryos are kept in the laboratory while the material is being screened for a diagnosis. For information on disorders, screening, and/or candidacy for this procedure, please contact our office.